229 related articles for article (PubMed ID: 17999841)
1. Drug-eluting stents: a systematic review and economic evaluation.
Hill RA; Boland A; Dickson R; Dündar Y; Haycox A; McLeod C; Mujica Mota R; Walley T; Bagust A
Health Technol Assess; 2007 Nov; 11(46):iii, xi-221. PubMed ID: 17999841
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery stents: a rapid systematic review and economic evaluation.
Hill R; Bagust A; Bakhai A; Dickson R; Dündar Y; Haycox A; Mujica Mota R; Reaney A; Roberts D; Williamson P; Walley T
Health Technol Assess; 2004 Sep; 8(35):iii-iv, 1-242. PubMed ID: 15361315
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.
Greenhalgh J; Hockenhull J; Rao N; Dundar Y; Dickson RC; Bagust A
Cochrane Database Syst Rev; 2010 May; (5):CD004587. PubMed ID: 20464732
[TBL] [Abstract][Full Text] [Related]
4. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
Varani E; Guastaroba P; Di Tanna GL; Saia F; Balducelli M; Campo G; Vignali L; Rossi R; Manari A; Piovaccari G; De Palma R; Marzocchi A
EuroIntervention; 2010 Apr; 5(8):953-61. PubMed ID: 20542781
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
Ferko N; Ferrante G; Hasegawa JT; Schikorr T; Soleas IM; Hernandez JB; Sabaté M; Kaiser C; Brugaletta S; de la Torre Hernandez JM; Galatius S; Cequier A; Eberli F; de Belder A; Serruys PW; Valgimigli M
Catheter Cardiovasc Interv; 2017 May; 89(6):994-1002. PubMed ID: 27527508
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literature.
Neyt M; Van Brabandt H; Devriese S; De Laet C
Health Policy; 2009 Jul; 91(2):107-20. PubMed ID: 19135756
[TBL] [Abstract][Full Text] [Related]
8. [Can PCI with drug-eluting stents replace coronary artery bypass surgery? A comparative economic analysis regarding both therapeutic options based on clinical 12-month data reflecting the German social health care insurance system].
Fricke FU; Silber S
Herz; 2005 Jun; 30(4):332-8. PubMed ID: 15965811
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis.
Kuukasjärvi P; Räsänen P; Malmivaara A; Aronen P; Sintonen H
Int J Technol Assess Health Care; 2007; 23(4):473-9. PubMed ID: 17937836
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
[TBL] [Abstract][Full Text] [Related]
11. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.
Katsanos K; Geisler BP; Garner AM; Zayed H; Cleveland T; Pietzsch JB
BMJ Open; 2016 May; 6(5):e011245. PubMed ID: 27160845
[TBL] [Abstract][Full Text] [Related]
12. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
Ariyaratne TV; Yap CH; Ademi Z; Rosenfeldt F; Duffy SJ; Billah B; Reid CM
Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):261-270. PubMed ID: 29474722
[TBL] [Abstract][Full Text] [Related]
14. Clinical, humanistic, and economic outcomes between drug-eluting stent (DES) and bare metal stent (BMS): 18-month follow-up study.
Lee VW; Cheng FW; Choi AY; Fong ST; Yu CM; Yan BP
J Med Econ; 2017 Mar; 20(3):239-245. PubMed ID: 27737596
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study.
Rodriguez AE; Maree A; Tarragona S; Fernandez-Pereira C; Santaera O; Rodriguez Granillo AM; Rodriguez-Granillo GA; Russo-Felssen M; Kukreja N; Antoniucci D; Palacios IF; Serruys PW;
EuroIntervention; 2009 Jun; 5(2):255-64. PubMed ID: 20449934
[TBL] [Abstract][Full Text] [Related]
17. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial.
Rodriguez AE; Rodriguez-Granillo AM; Antoniucci D; Mieres J; Fernandez-Pereira C; Rodriguez-Granillo GA; Santaera O; Rubilar B; Palacios IF; Serruys PW;
Catheter Cardiovasc Interv; 2012 Sep; 80(3):385-94. PubMed ID: 22109997
[TBL] [Abstract][Full Text] [Related]
19. Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
Philip F; Stewart S; Southard JA
Catheter Cardiovasc Interv; 2016 Jul; 88(1):38-48. PubMed ID: 26916633
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
